Biomerica, Inc Stock News

Biomerica Inc. (NASDAQ: BMRA) today announced they have signed definitive agreements with Mayo Clinic to join the clinical trial for Biomerica’s new InFoods® diagnostic-guided therapy (DGT), design

By M. Marin NASDAQ:BMRA READ THE FULL BMRA RESEARCH REPORT In response to the current global health crisis, Biomerica (NASDAQ:BMRA) has developed a high-volume rapid 10-minute point-of-care test for e

Biomerica, Inc. (NASDAQ:BMRA) shareholders might be concerned after seeing the share price drop 16% in the last month...

In the current session, Biomerica Inc. (NASDAQ: BMRA) is trading at $7.64, after a 16.6% spike. Over the past month, the stock increased by 2.41%, and in the past year, by 222.36%. With performance li

New high-volume production test allows Biomerica to expand international distribution to better meet demand of its 10-minute test for coronavirus exposure. Biomerica also announced it is now filling

NEW YORK (AP) —The following list shows the Nasdaq stocks that have gone up the most and down the most based on percent of change for 2019. No securities trading below 1000 shares are in

ResearchAndMarkets.com published a new article on the healthcare industry, "COVID-19: 10 Companies at the Forefront of Antibody Test Development"

Biomerica, Inc. (BMRA) today reported net sales of $3,967,712 for the nine months ending February 29, 2020, compared to $4,034,822 for the period ended February 28, 2019. For the nine months ended Fe

A Citigroup report argues that mass antibody testing can quickly locate millions of Americans with immunity to Covid-19. There are snags: Who will provide the tests, are they accurate, and does infect

Companies In The News Are: NEPT, BMRA, LK, WBA

Companies In The News Are: NEPT, BMRA, LK, WBA

ION Geophysical (NYSE:IO) +120% on expecting big jump in Q1 revenues.Neptune Wellness Solutions (NASDAQ:NEPT) +47% on receiving health Canada authorization to commercialize natural, plant-based hand

Un análisis de sangre rápido podría ayudarte a averiguar si has desarrollado anticuerpos para el nuevo coronavirus, lo que implica que ya lo has tenido.

Biomerica Inc. (NASDAQ: BMRA) today announced it has signed two separate definitive license agreements with Mount Sinai’s Icahn School of Medicine in New York to license technologies pertaining to a

Citigroup analysts say that 60% of U.S. workers could be given quick, point-of-care blood tests by the end of this month, paving the way for the healthy to return to work. But from where are these tes